Roger M. Lyons
Roger M. Lyons publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Multiple Myeloma Research and Treatments.
- World rank
- #470,138 of 7,710,434 ranked researchers
- Rank in United States
- #164,587 of 1,627,098
- Works
- 204
- Citations
- 11k
- Citations per work
- 53.0
What does Roger M. Lyons research?
Roger M. Lyons's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13767.4%
- Medicine13767.4%
- Everything else5024.6%
- Life Sciences168.0%
- 1Hematology36% of their works
- 2Genetics20% of their works
- 3Molecular Biology8% of their works
- 4Oncology5% of their works
- 5Pathology and Forensic Medicine3% of their works
- 6Cardiology and Cardiovascular Medicine3% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Platelet Disorders and Treatments
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
- Protein Degradation and Inhibitors
Which keywords describe Roger M. Lyons's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, JAK2 Mutation, Myelofibrosis, Diagnosis Criteria, International Myeloma Working Group and Platelets.
- BET Bromodomains
- Sickle-cell Disease
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Platelets
- Diagnosis Criteria
- JAK2 Mutation
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Myelofibrosis
- International Myeloma Working Group
- Thrombosis
- Imatinib
- Genomic Aberrations
- Thalassemia
- PROTACs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Prognostic Factors982 topics
- AML651 topic
- Acute Myeloid Leukemia651 topic
- JAK2 Mutation601 topic
- Myelofibrosis601 topic
- Diagnosis Criteria411 topic
- International Myeloma Working Group411 topic
- Platelets391 topic
- Thrombosis391 topic
- BCR-ABL361 topic
- Imatinib361 topic
- Chronic Lymphocytic Leukemia331 topic
- Genomic Aberrations331 topic
- Sickle-cell Disease241 topic
- Thalassemia241 topic
- BET Bromodomains181 topic
- PROTACs181 topic
Where does Roger M. Lyons work?
Roger M. Lyons's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does Roger M. Lyons have?
OpenAlex counts 204 works and 10,807 citations for Roger M. Lyons, an h-index of 43, ranking #470,138 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Roger M. Lyons. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.